CV absolute risk tool may not influence prescribing

The finding from a Sydney trial coincided with the release last week of new guidelines on CV risk management.

Lead study author Dr Sanjyot Vagholkar said an increasing number of GPs were using absolute cardiovascular risk but it was not routine.

Dr Vagholkar, staff specialist at the General Practice Unit of Fairfield Hospital, Sydney, said the findings also suggested some overtreatment of low risk patients.

The study, presented at the NPS National Medicines Symposium in Sydney last week, was conducted between 2008 and 2010 and involved 36 GPs who assessed cardiovascular risk among 1074 patients aged 45–69